GlaxoSmithKline and Theravance have announced their intent to file a new drug application in Japan for Relvar Ellipta, a combination inhaler for COPD.
Tri-anim Health Services and parent company Sarnova have entered into a master distribution agreement with Ambu to distribute Ambu's videoscope, laryngoscope, laryngeal masks, and pain management products.
Philips Respironics is showcasing its latest portfolio of sleep-disordered breathing and respiratory solutions at ERS 2015 in Amsterdam.
Data indicated a sustainability of benefit in pulmonary arterial hypertension (PAH) patients using INOpulse.
In patients with late-onset asthma who have elevated blood eosinophils, the anti-interleukin 5 (IL-5) antibody reslizumab can reduce exacerbations by 75% compared with placebo.
A safety alert has been issued that indicates a risk of troubled breathing in children aged 17 years and younger treated with tramadol.
iGetBetter, a supplier of mobile digital health solutions, has announced the addition of the COPD Care Plan to its library.
Boehringer Ingelheim will present new data at ERS 2015 on Spiolto Respimat for COPD, OFEV for IPF, and Spiriva Respimat in asthma.
Medtronic's superDimension navigation system includes LungGPS technology, which is the first of its kind to enable electromagnetic navigation bronchoscopy procedures intended to diagnose lung cancer.
Vyntus WALK allows clinicians to conduct the 6-minute walk test (6MWT) fully independent of any external wires or means of connection.
Proteostasis Therapeutics has raised $37 million in new funding to develop its lead product candidate for the treatment of cystic fibrosis.
The FDA has granted a Fast Track designation to MediciNova's drug formulation MN-001 aimed at treating idiopathic pulmonary fibrosis (IPF).
"Smart Oxygen" is designed to be used by patients who require supplemental oxygen such as those suffering with advanced COPD.
Using ndd Medical’s EasyOne spirometer, COPD patients were as adept in monitoring lung function at home as the professionals who performed their baseline measurements.
The Phase 3 program, designed to support the registration of the product in the US, includes two replicate three-month efficacy studies and a single 12-month safety study.
Vernalis Therapeutics has announced that Tuzistra XR is now available to adult patients and physicians in the United States.
The First Response Monitor is a nose clip that measures and monitors vital signs of multiple trauma patients in disasters and battlefield situations.
According to Nasdaq, Nanosphere has received FDA 510(k) clearance for its Verigene Respiratory Pathogens Flex Nucleic Acid Test.
Luminex Corporation has submitted a a 510(k) application to the FDA for its NxTAG respiratory pathogen panel, according to PharmaBiz.
A team of scientists at the Wyss Institute has developed an improved sepsis device that cleanses pathogens and toxins from blood flowing through a dialysis-like circuit.